These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 33879872)

  • 1. Prodromal Parkinson disease subtypes - key to understanding heterogeneity.
    Berg D; Borghammer P; Fereshtehnejad SM; Heinzel S; Horsager J; Schaeffer E; Postuma RB
    Nat Rev Neurol; 2021 Jun; 17(6):349-361. PubMed ID: 33879872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
    Doppler K; Jentschke HM; Schulmeyer L; Vadasz D; Janzen A; Luster M; Höffken H; Mayer G; Brumberg J; Booij J; Musacchio T; Klebe S; Sittig-Wiegand E; Volkmann J; Sommer C; Oertel WH
    Acta Neuropathol; 2017 Apr; 133(4):535-545. PubMed ID: 28180961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tract-Based Spatial Statistics Reveal Lower White Matter Integrity Specific to Idiopathic Rapid Eye Movement Sleep Behavior Disorder as a Proxy for Prodromal Parkinson's Disease.
    Ohlhauser L; Smart CM; Gawryluk JR
    J Parkinsons Dis; 2019; 9(4):723-731. PubMed ID: 31498130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and imaging evidence of brain-first and body-first Parkinson's disease.
    Horsager J; Knudsen K; Sommerauer M
    Neurobiol Dis; 2022 Mar; 164():105626. PubMed ID: 35031485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in markers of prodromal Parkinson disease.
    Postuma RB; Berg D
    Nat Rev Neurol; 2016 Oct; 12(11):622-634. PubMed ID: 27786242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prodromal PD: A new nosological entity.
    Schaeffer E; Postuma RB; Berg D
    Prog Brain Res; 2020; 252():331-356. PubMed ID: 32247370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson Disease-Related Brain Metabolic Patterns and Neurodegeneration in Isolated REM Sleep Behavior Disorder.
    Shin JH; Lee JY; Kim YK; Yoon EJ; Kim H; Nam H; Jeon B
    Neurology; 2021 Jul; 97(4):e378-e388. PubMed ID: 34011571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodromal Parkinson's Disease: The Decade Past, the Decade to Come.
    Postuma RB; Berg D
    Mov Disord; 2019 May; 34(5):665-675. PubMed ID: 30919499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimaging of rapid eye movement sleep behavior disorder and its relation to Parkinson's disease.
    Valli M; Uribe C; Mihaescu A; Strafella AP
    J Neurosci Res; 2022 Oct; 100(10):1815-1833. PubMed ID: 35790021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
    Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
    Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four-Year Follow-up of [
    Kogan RV; Janzen A; Meles SK; Sittig E; Renken RJ; Gurvits V; Mayer G; Leenders KL; Oertel WH;
    Mov Disord; 2021 Jan; 36(1):230-235. PubMed ID: 32909650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the MDS research criteria for prodromal Parkinson's disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort.
    Fereshtehnejad SM; Montplaisir JY; Pelletier A; Gagnon JF; Berg D; Postuma RB
    Mov Disord; 2017 Jun; 32(6):865-873. PubMed ID: 28429825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease.
    Pagano G; De Micco R; Yousaf T; Wilson H; Chandra A; Politis M
    Neurology; 2018 Sep; 91(10):e894-e905. PubMed ID: 30089615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prodromal Parkinson disease in patients with idiopathic hyposmia.
    Marrero-González P; Iranzo A; Bedoya D; Serradell M; Niñerola-Baizán A; Perissinotti A; Gaig C; Vilaseca I; Alobid I; Santamaría J; Mullol J
    J Neurol; 2020 Dec; 267(12):3673-3682. PubMed ID: 32676768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid eye movement sleep behavior disorder and the link to alpha-synucleinopathies.
    Barone DA; Henchcliffe C
    Clin Neurophysiol; 2018 Aug; 129(8):1551-1564. PubMed ID: 29883833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson disease: Peripheral α-synuclein deposits - prodromal markers for Parkinson disease?
    Wood H
    Nat Rev Neurol; 2016 May; 12(5):249. PubMed ID: 27080519
    [No Abstract]   [Full Text] [Related]  

  • 17. How specific are non-motor symptoms in the prodrome of Parkinson's disease compared to other movement disorders?
    Moscovich M; Heinzel S; Postuma RB; Reilmann R; Klockgether T; Jacobi H; Höglinger G; Berg D
    Parkinsonism Relat Disord; 2020 Dec; 81():213-218. PubMed ID: 33039276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty Years After: Another Case Report of Melatonin Effects on REM Sleep Behavior Disorder, Using Serial Dopamine Transporter Imaging.
    Kunz D; Bes F
    Neuropsychobiology; 2017; 76(2):100-104. PubMed ID: 29860260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From Rapid Eye Movement Sleep Behavior Disorder to Parkinson's Disease: Possible Predictive Markers of Conversion.
    Zhou L; Zhu L; Liu J
    ACS Chem Neurosci; 2019 Feb; 10(2):824-827. PubMed ID: 30222303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease.
    Meles SK; Oertel WH; Leenders KL
    Mol Med; 2021 Sep; 27(1):111. PubMed ID: 34530732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.